ALSO NOTED: Perrigo, Teva get clearance for generic Zyrtec-D; Pfizer sues Impax over copycat Detrol;

> Perrigo and its partner Teva Pharmaceutical Industries got the FDA nod for their over-the-counter version of McNeil Consumer Healthcare's Zyrtec-D; McNeil, a Johnson & Johnson unit, launched its OTC version in January. Report

> Pfizer sued Impax Laboratories over the latter's plans to launch a generic competitor to the overactive-bladder med Detrol LA. Report

> A Connecticut bill that would limit drug makers' gifts to doctors is languishing in the state legislature. Report

> APP Pharmaceuticals reported a 70 percent drop in fourth-quarter profits to $8.5 million on revenues of $194.6 million. Report

Most popular article this week: Schering-Plough slashes jobs. Report

And Finally... Even fictional drugs can cause controversy, as a British TV drama discovered the hard way. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.